HIGHLIGHTS
- who: Daisuke Hisamatsu and colleagues from the Intractable Disease Research Center, Juntendo University Graduate School of Medicine, Hongo, Bunkyo-ku, Tokyo, Japan have published the article: CD73-Positive Cell Spheroid Transplantation Attenuates Colonic Atrophy, in the Journal: Pharmaceutics 2023, 845 of /2023/
- what: The authors hypothesized that a uniform population of CD73+ cells, rather than conventional heterogeneous MSCs, would have more predictive or controlled therapeutic efficacy when considering cell transplantation at the clinical stage. The study provides insights into MSC transplantation therapy for IBD and suggests whether CD73+ cells are effective in this regard. The . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.